InvestorsHub Logo
Followers 9
Posts 387
Boards Moderated 0
Alias Born 03/10/2020

Re: ElleDe post# 17181

Wednesday, 05/20/2020 6:27:23 PM

Wednesday, May 20, 2020 6:27:23 PM

Post# of 19459
3:10 Development of a Single Dose Vaccine Against COVID-19 Using GV-MVA-VLP Vector Platform

Farshad Guirakhoo, PhD, CSO, GeoVax

In only a few months, the emerging COVID-19 has caused a global pandemic, killed hundreds of thousands, and crippled the global economy. A safe and effective vaccine to control this new pathogen is desperately needed. We have leveraged our unique, safe, live viral GV-MVA-VLP™ platform to develop multiple vaccine candidates against COVID-19. These will be down selected to one in appropriate challenge models for safety and efficacy before entering into humans
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GOVX News